Tissue Regenix appoints Gareth Hywel Jones as CFO

Writer, Stock Market Wire
Wednesday, July 4, 2018 - 09:25

Regenerative medical devices company Tissue Regenix Group said it had appointed Gareth Hywel Jones as its new chief financial officer, effective at the end of November.

Current interim CFO, Paul Below, would remain with the group to facilitate an orderly hand-over.

Jones was currently CFO of Applied Graphene Materials.

At 9:25am: (LON:TRX) Tissue Regenix Group PLC share price was -0.15p at 10.75p


Related content

Tissue Regenix secures $20m in loan facilities

Regenerative medical devices company Tissue Regenix Group said some of its subsidiaries had agreed with MidCap Financial Trust to access a revolving credit facility and...

Tue, 04/06/2019 - 07:31


Tissue Regenix CEO to return to full-time duties after medical treatment

Regenerative medical devices company Tissue Regenix Group said chief executive Steve Couldwell would return to full time duties during June.

Couldwell had taken a leave...

Tue, 21/05/2019 - 08:25


Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48


Tissue Regenix moves closer to profitability after revenue jumps

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more...

Mon, 04/02/2019 - 14:17


Tissue Regenix signs European distribution agreement with Arthrex

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with...

Tue, 13/11/2018 - 09:19